|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Alexza Pharmaceuticals
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Alexza Pharmaceuticals (Alexza) is focused on the R&D, and commercialization of novel, proprietary products for the acute treatment of central nervous system (CNS) conditions. The company's product candidates are based on its proprietary technology, the Staccato system. It is headquartered in Mountain View, California.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: DURECT Corporation
Company Financials: Cadence Pharmaceuticals
Company Financials: Arena Pharmaceuticals, Inc.
Company Financials: Labopharm Inc.
Company Financials: DUSA Pharmaceuticals, Inc.
Company Financials: Inspire Pharmaceuticals
Company Financials: Jazz Pharmaceuticals, Inc.
Company Financials: Oncogenex Pharmaceuticals, Inc.
Company Financials: Watson Pharmaceuticals, Inc.
Company Financials: ISTA Pharmaceuticals, Inc.
|
|
|
|
